Featured Publication:  Pfizer Oncology Team identifies potential therapeutic targets for lung cancer published in the EMBO Journal in May, 2015.

Mediomics wishes to congratulate Dr. Stephen Dann and his team for their important discovery of the reciprocal regulation between extracellular Met uptake and epigenetic state in malignant cells. They identified Lat1, an amino acid transporter, as a downstream biomarker of EZH2 activity and demonstrated the critical role of Lat1 in supporting tumor growth.

Mediomics is proud to serve such innovative clients in cancer research and wishes them the best of luck in their future projects!

To read more about Dr. Dann’s research, access the link here.